Filing Details

Accession Number:
0001438133-21-000188
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-28 17:07:55
Reporting Period:
2021-10-27
Accepted Time:
2021-10-28 17:07:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866570 James Leal C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Svp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-27 1,666 $51.50 5,417 No 4 M Direct
Common Stock Acquisiton 2021-10-27 238 $82.34 5,655 No 4 M Direct
Common Stock Disposition 2021-10-27 1,904 $130.34 3,751 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-10-27 1,666 $51.50 1,666 $51.50
Common Stock Stock Option Disposition 2021-10-27 238 $82.34 238 $82.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,667 No 4 M Direct
7,386 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
  3. The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
  4. The expiration date for these options is 10 years from the date of grant.
  5. The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.